SCHEMBL8479136

SCHEMBL8479136

CC(=O)N(Br)c1cccc(Cl)c1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ PBRM1 Q86U86 1/20 0.40
▸ DPP4 P27487 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ FABP3 P05413 2/20 0.38
▸ FABP4 P15090 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ANO1 Q5XXA6 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ CA9 Q16790 1/20 0.34
▸ CA14 Q9ULX7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11157305 0.79 ALDH1A1 (0.47) GAAALDH1A1PBRM1DPP4KDM4E
SCHEMBL9094620 0.74 PBRM1 (0.41) GAAALDH1A1PBRM1KDM4EHSD17B10
SCHEMBL1939814 0.73 GAA (0.46) GAAALDH1A1HSD17B10TSHRKMT2A
SCHEMBL8478831 0.73 TSHR (0.50) ALDH1A1PBRM1KDM4EHSD17B10FABP3
SCHEMBL80183 0.73 ALDH1A1 (0.64) ALDH1A1PBRM1DPP4KDM4EHSD17B10
SCHEMBL6640962 0.73 TSHR (0.53) ALDH1A1PBRM1DPP4KDM4EHSD17B10
SCHEMBL9360259 0.72 ALDH1A1 (0.48) GAAALDH1A1KDM4EHSD17B10TSHR
SCHEMBL1041643 0.71 ALDH1A1 (0.61) ALDH1A1PBRM1DPP4KDM4EHSD17B10
Hydrochloric Acid SCHEMBL8042412 0.71 ALDH1A1 (0.61) ALDH1A1PBRM1DPP4KDM4EHSD17B10
SCHEMBL7425018 0.71 ALDH1A1 (0.61) ALDH1A1PBRM1DPP4KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925647-A TREATMENT OF INSULIN NON-INSULIN DEPENDENT DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1999-07-20 — — US disclosed
US-5681958-A TREATMENT OF DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1997-10-28 — — US disclosed
WO-1996010015-A1 CRYPTOLEPINE ANALOGS WITH HYPOGLYCEMIC ACTIVITY SHAMAN PHARMACEUTICALS, INC. (US) 1996-04-04 — — WO disclosed
Send feedback